A Study of Intrapleural Administration of Bevacizumab and Camrelizumab for Malignant Pleural Effusion
Clinical trial NCT05330065 · UNKNOWN
Trial details
- NCT number
- NCT05330065
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-01
- Primary completion
- 2023-08-31
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.